Lenalidomide and its impact on exanthematous reactions: a case report

Lenalidomide is a drug used mainly in the treatment of Multiple Myeloma and Myelodysplastic Syndrome. Despite its therapeutic benefits, lenalidomide can cause several adverse effects, including exanthematous reactions that can appear unexpectedly and cause discomfort to the patient. These skin react...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristiana Vieira-Maia, José E. Ramos, Ana C. Morgado
Format: Article
Language:English
Published: Sociedade Portuguesa de Dermatologia e Venereologia 2025-04-01
Series:Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Subjects:
Online Access:https://www.portuguesejournalofdermatology.com/frame_eng.php?id=224
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849423242314383360
author Cristiana Vieira-Maia
José E. Ramos
Ana C. Morgado
author_facet Cristiana Vieira-Maia
José E. Ramos
Ana C. Morgado
author_sort Cristiana Vieira-Maia
collection DOAJ
description Lenalidomide is a drug used mainly in the treatment of Multiple Myeloma and Myelodysplastic Syndrome. Despite its therapeutic benefits, lenalidomide can cause several adverse effects, including exanthematous reactions that can appear unexpectedly and cause discomfort to the patient. These skin reactions can be mild or severe and sometimes require the discontinuation of the lenalidomide treatment. In this case study, we will present the case of an 86-year-old man with a history of multiple myeloma who was on his fifth cycle of lenalidomide 10 mg and dexamethasone 20 mg, who was seen at the Health Center for constipation after two visits to the emergency department. During the consultation, the objective examination revealed a scattered maculopapular rash, probably secondary to lenalidomide. Timely assessment and guidance in these situations can be crucial to the patient’s prognosis. Anamnesis is one of the fundamental pillars of medical diagnosis.
format Article
id doaj-art-7091ec7028d34e0d93d833e4c8f6e185
institution Kabale University
issn 2182-2395
2182-2409
language English
publishDate 2025-04-01
publisher Sociedade Portuguesa de Dermatologia e Venereologia
record_format Article
series Revista da Sociedade Portuguesa de Dermatologia e Venereologia
spelling doaj-art-7091ec7028d34e0d93d833e4c8f6e1852025-08-20T03:30:41ZengSociedade Portuguesa de Dermatologia e VenereologiaRevista da Sociedade Portuguesa de Dermatologia e Venereologia2182-23952182-24092025-04-01832Lenalidomide and its impact on exanthematous reactions: a case reportCristiana Vieira-Maia0José E. Ramos1Ana C. Morgado2General Family Medicine, USF Aquae Flaviae, ULS Trás - Os - Montes e Alto Douro, Chaves, PortugalGeneral Family Medicine, USF Aquae Flaviae, ULS Trás - Os - Montes e Alto Douro, Chaves, PortugalGeneral Family Medicine, USF Aquae Flaviae, ULS Trás - Os - Montes e Alto Douro, Chaves, PortugalLenalidomide is a drug used mainly in the treatment of Multiple Myeloma and Myelodysplastic Syndrome. Despite its therapeutic benefits, lenalidomide can cause several adverse effects, including exanthematous reactions that can appear unexpectedly and cause discomfort to the patient. These skin reactions can be mild or severe and sometimes require the discontinuation of the lenalidomide treatment. In this case study, we will present the case of an 86-year-old man with a history of multiple myeloma who was on his fifth cycle of lenalidomide 10 mg and dexamethasone 20 mg, who was seen at the Health Center for constipation after two visits to the emergency department. During the consultation, the objective examination revealed a scattered maculopapular rash, probably secondary to lenalidomide. Timely assessment and guidance in these situations can be crucial to the patient’s prognosis. Anamnesis is one of the fundamental pillars of medical diagnosis. https://www.portuguesejournalofdermatology.com/frame_eng.php?id=224Anamnesis. Adverse effects. Exanthema. Hypersensitivity. Late onset. Lenalidomide.
spellingShingle Cristiana Vieira-Maia
José E. Ramos
Ana C. Morgado
Lenalidomide and its impact on exanthematous reactions: a case report
Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Anamnesis. Adverse effects. Exanthema. Hypersensitivity. Late onset. Lenalidomide.
title Lenalidomide and its impact on exanthematous reactions: a case report
title_full Lenalidomide and its impact on exanthematous reactions: a case report
title_fullStr Lenalidomide and its impact on exanthematous reactions: a case report
title_full_unstemmed Lenalidomide and its impact on exanthematous reactions: a case report
title_short Lenalidomide and its impact on exanthematous reactions: a case report
title_sort lenalidomide and its impact on exanthematous reactions a case report
topic Anamnesis. Adverse effects. Exanthema. Hypersensitivity. Late onset. Lenalidomide.
url https://www.portuguesejournalofdermatology.com/frame_eng.php?id=224
work_keys_str_mv AT cristianavieiramaia lenalidomideanditsimpactonexanthematousreactionsacasereport
AT joseeramos lenalidomideanditsimpactonexanthematousreactionsacasereport
AT anacmorgado lenalidomideanditsimpactonexanthematousreactionsacasereport